1. Stocks
  2. Vanda Pharmaceuticals Inc
  3. Swot
swot-logo

Vanda Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Vanda Pharmaceuticals Inc has 6 Strengths, 19 Weaknesses, 0 Opportunities and 4 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

PEG lower than Industry PEG

Companies with Low Debt

Top Gainers

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Near 52 Week Low

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

RSI indicating price weakness

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Decreased Shareholding in Past Month

Red Flags: Weakening Technicals and Share Price Decline

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Promoters increasing shareholding QoQ